Literature DB >> 22871571

GAB2--a scaffolding protein in cancer.

Sarah J Adams1, Iraz T Aydin, Julide T Celebi.   

Abstract

Adaptor or scaffolding proteins mediate protein-protein interactions that drive the formation of protein complexes. Grb2-associated binding protein 2 (GAB2) scaffolding protein is an intermediary molecule that links plasma membrane receptor signaling including receptor tyrosine kinases with the downstream effectors, such as protein tyrosine phosphatase, nonreceptor type 11 (SHP2), p85 subunit of phosphoinositide-3 kinase (PI3-K), phospholipase C-gamma 1 (PLC-γ), v-crk sarcoma virus CT10 (CRK), Src homology 2 domain containing transforming protein 1 (SHC), and SH2 containing inositol phosphatase (SHIP). Although, well described in signal transduction, its role in cancer has recently been emerging especially in leukemia, breast and ovarian cancer, and melanoma. GAB2 is essential for two major signal transduction pathways in cancer, the PI3-K-AKT and extracellular signal-regulated kinase (ERK) signaling pathways, and thus regulates a number of key cellular processes. This review focuses on structure and function of GAB2, its regulatory proteins, emerging role in cancer, and potential as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871571      PMCID: PMC3810274          DOI: 10.1158/1541-7786.MCR-12-0352

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  61 in total

1.  Epidermal growth factor-induced DNA synthesis. Key role for Src phosphorylation of the docking protein Gab2.

Authors:  Mei Kong; Catherine Mounier; Victor Dumas; Barry I Posner
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

2.  Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.

Authors:  H Gu; J C Pratt; S J Burakoff; B G Neel
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

3.  Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).

Authors:  Michaela Scherr; Anuhar Chaturvedi; Karin Battmer; Iris Dallmann; Beate Schultheis; Arnold Ganser; Matthias Eder
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

4.  Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias.

Authors:  Noria Harir; Christian Pecquet; Marc Kerenyi; Karoline Sonneck; Boris Kovacic; Remy Nyga; Marie Brevet; Isabelle Dhennin; Valerie Gouilleux-Gruart; Hartmut Beug; Peter Valent; Kaiss Lassoued; Richard Moriggl; Fabrice Gouilleux
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development.

Authors:  Emmy D G Fleuren; Sandra O'Toole; Ewan K Millar; Catriona McNeil; Elena Lopez-Knowles; Alice Boulghourjian; David R Croucher; Daniel Schramek; Tilman Brummer; Josef M Penninger; Robert L Sutherland; Roger J Daly
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

6.  The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer.

Authors:  A Mira; C Isella; T Renzulli; D Cantarella; M L Martelli; E Medico
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

7.  Focal amplification and oncogene dependency of GAB2 in breast cancer.

Authors:  M Bocanegra; A Bergamaschi; Y H Kim; M A Miller; A B Rajput; J Kao; A Langerød; W Han; D-Y Noh; S S Jeffrey; D G Huntsman; A-L Børresen-Dale; J R Pollack
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 8.  Amplification of oncogenes in human cancer cells.

Authors:  M Schwab
Journal:  Bioessays       Date:  1998-06       Impact factor: 4.345

9.  GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

Authors:  Y Yang; J Wu; A Demir; M Castillo-Martin; R D Melamed; G Zhang; M Fukunaga-Kanabis; R Perez-Lorenzo; B Zheng; D N Silvers; G Brunner; S Wang; R Rabadan; C Cordon-Cardo; J T Celebi
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

10.  Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.

Authors:  Y Wang; Q Sheng; M A Spillman; K Behbakht; H Gu
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

View more
  44 in total

1.  Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model.

Authors:  Sean J Miller; Jenna C Glatzer; Yi-Chun Hsieh; Jeffrey D Rothstein
Journal:  J Neurogenet       Date:  2018-11-06       Impact factor: 1.250

2.  Gab2 is a novel prognostic factor for colorectal cancer patients.

Authors:  Chenbo Ding; Junmin Luo; Weina Yu; Shaoying Gao; Liwen Yang; Chao Chen; Jihong Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.

Authors:  Oscar Lindblad; Julhash U Kazi; Lars Rönnstrand; Jianmin Sun
Journal:  Cell Mol Life Sci       Date:  2015-06-04       Impact factor: 9.261

4.  Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.

Authors:  Xiaocui Zhang; Genevieve Lavoie; Loic Fort; Edward L Huttlin; Joseph Tcherkezian; Jacob A Galan; Haihua Gu; Steven P Gygi; Sebastien Carreno; Philippe P Roux
Journal:  Mol Cell Biol       Date:  2013-02-11       Impact factor: 4.272

5.  A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening.

Authors:  Jing-Ping Zhang; Zhihui Song; Hong-Bo Wang; Lang Lang; Yuan-Zhong Yang; Wenming Xiao; Daniel E Webster; Wei Wei; Stefan K Barta; Marshall E Kadin; Louis M Staudt; Masao Nakagawa; Yibin Yang
Journal:  Blood       Date:  2019-05-31       Impact factor: 22.113

6.  Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.

Authors:  Erin L Marcotte; Nathan Pankratz; James F Amatruda; A Lindsay Frazier; Mark Krailo; Stella Davies; Jacqueline R Starr; Ching C Lau; Michelle Roesler; Erica Langer; Caroline Hallstrom; Anthony J Hooten; Jenny N Poynter
Journal:  Genes Chromosomes Cancer       Date:  2017-04-04       Impact factor: 5.006

7.  Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.

Authors:  Hui Liu; Gang Li; Weitao Zeng; Pengxing Zhang; Feiyan Fan; Yanyang Tu; Yongsheng Zhang
Journal:  Med Oncol       Date:  2014-07-08       Impact factor: 3.064

8.  A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation.

Authors:  Reza Saleki; Todd Christensen; Weihua Liu; Xiaowen Wang; Qing C Chen; Matthew Aakre; Nuno M V Gomes; Borislav A Alexiev; Joseph Schappert; Maria R Baer; Ying S Zou
Journal:  Leuk Lymphoma       Date:  2014-08-20

9.  Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Authors:  Weidong Ji; Lanling Xu; Haiyun Zhou; Suishan Wang; Yan Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.

Authors:  Yuyan Chen; Qingqing Liu; Miaomiao Wu; Manhua Li; Haifang Ding; Xiaohang Shan; Jinxia Liu; Tao Tao; Runzhou Ni; Xudong Chen
Journal:  Tumour Biol       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.